Literature DB >> 2854214

Multiple electrophysiological actions of amiodarone on guinea pig heart.

M Aomine1.   

Abstract

The cellular electrophysiologic effects of acute exposure to amiodarone (AM) on guinea pig papillary muscle (PM) and Purkinje fibres (PF) were investigated by means of conventional microelectrode techniques. Superfusion with AM less than 1.1 x 10(-4) mol/l reduced the maximum rate of rise (Vmax) of the action potential (AP) upstroke phase 0 of both PM and PF stimulated at 1 Hz, without changing resting membrane potential (RMP) or action potential duration (APD). AM greater than 1.1 x 10(-4) mol/l decreased APD at all levels, accompanied by decreases in Vmax and RMP. PF AP's were much more sensitive to AM than PM. In contrast, chronic exposure (20 mg/kg/day, 3 1/2 weeks) prolonged PM APD at all levels and decreased Vmax. In addition, acute exposure shifted steady state inactivation of Vmax by 4-7 mV to more negative potentials. The decrease of Vmax was frequency- and concentration-dependent. Half-maximal inhibition (IC50) of Vmax by AM was affected by K+-induced membrane depolarization (in 4 mmol/l K+, IC50 congruent to 2.3 x 10(-4) mol/l; in 8 mmol/l K+, IC50 congruent to 9 x 10(-5) mol/l). Frequency-dependent inhibition of closed Na+ channels by AM was demonstrated and AM increased the time constant for recovery from Na+ channel blockade. Depression of PF plateau by AM was similar to the effects of tetrodotoxin (TTX). Finally, AM depolarized RMP of PM exposed to low K+. The multiplicity of changes suggests that AM exerts inhibitory effects on a number of ionic current components, including at least fast Na+ current, slow inward current, TTX-sensitive plateau and outward K+ currents. Possible implications with respect to the broad spectrum of antiarrhythmic activity exhibited by AM are considered.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2854214     DOI: 10.1007/bf00179335

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  42 in total

1.  Slow recovery from inactivation of inward currents in mammalian myocardial fibres.

Authors:  L S Gettes; H Reuter
Journal:  J Physiol       Date:  1974-08       Impact factor: 5.182

2.  Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride.

Authors:  M B Rosenbaum; P A Chiale; D Ryba; M V Elizari
Journal:  Am J Cardiol       Date:  1974-08       Impact factor: 2.778

Review 3.  Pharmacology of cardiac arrhythmias.

Authors:  D H Singer; R E Ten Eick
Journal:  Prog Cardiovasc Dis       Date:  1969-05       Impact factor: 8.194

4.  Use-dependent effects of amiodarone on Vmax in cardiac Purkinje and ventricular muscle fibers.

Authors:  A Varro; Y Nakaya; V Elharrar; B Surawicz
Journal:  Eur J Pharmacol       Date:  1985-06-19       Impact factor: 4.432

5.  Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone.

Authors:  J W Mason; L M Hondeghem; B G Katzung
Journal:  Circ Res       Date:  1984-09       Impact factor: 17.367

6.  Effects of butoprozine on ionic currents in frog atrial and ferret ventricular fibres. Comparison with amiodarone and verapamil.

Authors:  G Néliat; P Ducouret; M Moreau; Y M Gargouïl
Journal:  Arch Int Pharmacodyn Ther       Date:  1982-02

7.  Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.

Authors:  B McGovern; H Garan; R F Malacoff; J P DiMarco; G Grant; T D Sellers; J N Ruskin
Journal:  Am J Cardiol       Date:  1984-06-01       Impact factor: 2.778

8.  The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

9.  Effect of procainamide on transmembrane action potentials in guinea-pig papillary muscles as affected by external potassium concentration.

Authors:  H Sada; M Kojima; T Ban
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

Review 10.  Amiodarone: historical development and pharmacologic profile.

Authors:  B N Singh
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

View more
  1 in total

Review 1.  Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Authors:  J Gill; R C Heel; A Fitton
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.